These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3494847)

  • 1. Anti-Ro antibody in a population of German patients.
    Merle SP; Krippner H
    J Rheumatol; 1987 Feb; 14(1):185-6. PubMed ID: 3494847
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antinuclear antibodies, anti-SSA(Ro) and SSB(La) in diffuse connective tissue diseases].
    Assad RL; Gabriel Júnior A; Iglesias SS; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(3):103-8. PubMed ID: 3551017
    [No Abstract]   [Full Text] [Related]  

  • 3. Benign hypergammaglobulinemic purpura and anti-Ro(SSA) antibodies in undifferentiated connective tissue disease.
    Caporali R; Scatola C; Montecucco C
    J Rheumatol; 1996 Feb; 23(2):410-1. PubMed ID: 8882066
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
    Yamagata H; Akizuki M; Tojo T; Homma M
    Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of antinuclear and anti-native-DNA antibodies in connective tissue diseases].
    Guzmán L; González C; Arriagada M; Grisanti M; Meléndez M; Arinoviche R
    Rev Med Chil; 1982 Jan; 110(1):24-8. PubMed ID: 6760312
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibodies to soluble nuclear antigens and native DNA in patients with connective tissue diseases with antinuclear antibodies].
    Damilano G; Hübscher O; Fernández L; Arana RM
    Medicina (B Aires); 1983; 43(5):488-94. PubMed ID: 6371438
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-nucleolar antibodies in patients with connective tissue disease].
    Tanaka M
    Ryumachi; 1984 Jun; 24(3):173-82. PubMed ID: 6209811
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases.
    Lazzerini PE; Acampa M; Guideri F; Capecchi PL; Campanella V; Morozzi G; Galeazzi M; Marcolongo R; Laghi-Pasini F
    Arthritis Rheum; 2004 Apr; 50(4):1248-52. PubMed ID: 15077308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finger joint calcinosis followed by osteolysis in a patient with multisystem connective tissue disease and anti-Jo-1 antibody.
    Cohen MG; Ho KK; Webb J
    J Rheumatol; 1987 Jun; 14(3):605-8. PubMed ID: 3498039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunospecificities of antinuclear antibody in systemic connective tissue diseases in India.
    Narayanan K; Rajagopalan P; Malaviya AN
    Indian J Med Res; 1983 Jan; 77():87-95. PubMed ID: 6602765
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of the laboratory in rheumatology. Antibodies to nuclear and other intracellular antigens in the connective tissue diseases.
    Alarcón-Segovia D
    Clin Rheum Dis; 1983 Apr; 9(1):161-75. PubMed ID: 6191908
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti Ro/SSA positive undifferentiated connective tissue disease in a mother with a newborn with complete congenital heart block: a case report.
    Louthrenoo W; Boonyaratavej S; Sittiwangkul R; Sukitawut W
    J Med Assoc Thai; 1998 Aug; 81(8):633-6. PubMed ID: 9737117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical importance of antinuclear antibodies].
    Dabelić N; Cikes N
    Lijec Vjesn; 1997; 119(8-9):236-42. PubMed ID: 9481891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of connective tissue diseases with anti-ribonucleoprotein antibodies (in 28 patients) (author's transl)].
    Benhamou CL; Amor B; Menkes CJ; Delbarre F
    Ann Med Interne (Paris); 1982; 133(2):72-9. PubMed ID: 6979281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies to soluble nuclear antigens in connective tissue diseases].
    Rivero S; Jacobelli S
    Rev Med Chil; 1982 May; 110(5):433-8. PubMed ID: 6984534
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biological activity of the anticentromere antibody. Complement fixation capacity].
    Gabriel Júnior A; Assad RL; Iglesias SS; Kaneno R; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(1):1-5. PubMed ID: 3877333
    [No Abstract]   [Full Text] [Related]  

  • 20. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
    González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
    Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.